LIFE SCI 润色咨询

LIFE SCIENCES

出版年份:1973 年文章数:7314 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:2.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-02-26 侍郎 来自安徽省

    请问大家life sciences这个杂志必须要三次重复的WB图吗?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-02-20 ms4000000100009364 来自重庆

    2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-02-02 ms9000001986512880 来自河北省

    with editor 4天了,正常吗,一般不是with editor两天就给结果了

    6

    展开6条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-01-30 1489114dm38(暂无昵称) 来自四川省

    偏重的研究方向:肿瘤学
    经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿

    11

    展开11条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-02-19 Rambo 来自北京

    审稿速度:1.0 | 投稿命中率:95.0
    偏重的研究方向:中药提取物
    经验分享:2月16号投稿
    2月18号Decision in Process

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-02-26 ms4000000667943195 来自山东省

    请问这个杂志审稿费多少啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2024-01-02 594624370 来自四川省

    偏重的研究方向:细胞生物学
    经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂

    11

    展开11条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2020-06-08 121891d1m83(暂无昵称)

    我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2023-10-25 1304372fcam 来自北京

    偏重的研究方向:脑病;基础研究
    经验分享:10.2投稿
    10.4under review
    10.5送外审
    10.23 外审结束
    正在等待一审结果

    7

    展开7条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿,2月4号with editor,一直with editor到20号了,16天了还在with editor,邮件问了说是编辑还在审,要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了,正常吗,一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向:肿瘤学<br>经验分享:1.14头稿,1.28 with editor,1.29 under review,4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0<br>偏重的研究方向:中药提取物<br>经验分享:2月16号投稿<br>2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向:细胞生物学<br>经验分享:2023.12.27投稿,现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=601806, encodeId=7a5b60180676, content=我的文章刚投 状态栏就是Decision in Process,这样的状态10天了 是不是直接就是被拒了呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=824e2262569, createdName=121891d1m83(暂无昵称), createdTime=Mon Jun 08 15:01:05 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2164819, encodeId=866921648192d, content=偏重的研究方向:脑病;基础研究<br>经验分享:10.2投稿<br>10.4under review<br>10.5送外审<br>10.23 外审结束<br>正在等待一审结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01ef4788762, createdName=1304372fcam, createdTime=Wed Oct 25 13:33:56 CST 2023, time=2023-10-25, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2098259, encodeId=1a36209825979, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享:实时更新中<br>10.27 submit----with editor<br>10.29 under review<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27ff1606011, createdName=加油!, createdTime=Thu Nov 03 15:51:43 CST 2022, time=2022-11-03, status=1, ipAttribution=)]
    2022-11-03 加油!

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享:实时更新中
    10.27 submit----with editor
    10.29 under review

    17

    展开17条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分